I'm LongbridgeAI, I can summarize articles.In Friday's pre-market session, several healthcare stocks showed significant movement. Gainers included Immuron (up 64.9%), Akanda (up 27.52%), Niki BioSolutions (up 15.66%), GridAI Technologies (up 12.79%), Artelo Biosciences (up 11.4%), and XORTX Therapeutics (up 11.16%). Conversely, losers featured BioXcel Therapeutics (down 19.1%), Dogwood Therapeutics (down 9.75%), Gelteq (down 9.5%), Aethlon Medical (down 9.33%), bioAffinity Technologies (down 9.24%), and Cyclerion Therapeutics (down 6.05%).
Gainers
- Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million.
- Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68. The company's market cap stands at $1.9 million.
- Niki BioSolutions (NASDAQ:NIKI) stock rose 15.66% to $7.53. The market value of their outstanding shares is at $5.3 million.
- GridAI Technologies (NASDAQ:GRDX) shares moved upwards by 12.79% to $3.35. The market value of their outstanding shares is at $21.1 million.
- Artelo Biosciences (NASDAQ:ARTL) shares rose 11.4% to $6.93. The market value of their outstanding shares is at $3.4 million.
- XORTX Therapeutics (NASDAQ:XRTX) shares increased by 11.16% to $2.39. The company's market cap stands at $3.9 million.
Losers
- BioXcel Therapeutics (NASDAQ:BTAI) stock decreased by 19.1% to $0.1 during Friday's pre-market session. The market value of their outstanding shares is at $3.6 million.
- Dogwood Therapeutics (NASDAQ:DWTX) shares decreased by 9.75% to $2.13. The company's market cap stands at $80.2 million.
- Gelteq (NASDAQ:GELS) stock fell 9.5% to $0.81. The company's market cap stands at $9.5 million.
- Aethlon Medical (NASDAQ:AEMD) stock decreased by 9.33% to $1.75. The company's market cap stands at $1.3 million.
- bioAffinity Technologies (NASDAQ:BIAF) shares fell 9.24% to $11.6. The market value of their outstanding shares is at $7.5 million.
- Cyclerion Therapeutics (NASDAQ:CYCN) shares declined by 6.05% to $4.66. The market value of their outstanding shares is at $23.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock951characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.
